Dr. med. Bernd Becker Praxis am Markt

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Obesity
• Type 2 diabetes

Running trials

• Recruiting

  Efficacy and Safety of Once-Daily Oral ASC30 Compared with Placebo in Participants with Obesity or Overweight with Type 2 Diabetes Mellitus

  2026-526336-39-00· Phase 3· Ascletis Pharma (China) Co. Ltd.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity1 recruiting
• Type 2 diabetes1 recruiting